1992
DOI: 10.1093/toxsci/19.3.336
|View full text |Cite
|
Sign up to set email alerts
|

Adduction of Hemoglobin and Albumin in Vivo by Metabolites of Trichloroethylene, Trichloroacetate, and Dichloroacetate in Rats and Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
7
0
1

Year Published

1996
1996
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 0 publications
3
7
0
1
Order By: Relevance
“…Previous findings show that the half-life of albumin in humans is ;13 to 18 days, 27,28 whereas that of mice is ;1 day. 29 The findings in this in vivo pharmacokinetics study are therefore consistent with previous reports and support the establishment that the half-life of albumin in mice is shorter than humans.…”
Section: Resultssupporting
confidence: 92%
“…Previous findings show that the half-life of albumin in humans is ;13 to 18 days, 27,28 whereas that of mice is ;1 day. 29 The findings in this in vivo pharmacokinetics study are therefore consistent with previous reports and support the establishment that the half-life of albumin in mice is shorter than humans.…”
Section: Resultssupporting
confidence: 92%
“…3 In mice, the 10.4 h half-life for D3H44-L represents a 26-fold improvement. Interestingly, these halflives correlate with the reported half-life of albumin in these species of 5-6 days in rabbits (29) and 1 day in mice (30). Despite potential metabolism differences and the weaker affinity for human albumin (Table III), the 19-day half-life for human albumin suggests that large improvements in the halflife of a Fab in human are possible.…”
Section: ͼ250000supporting
confidence: 67%
“…A trifluoroanalogue of DCAC (trifluoroacylchloride) has been shown to acylate proteins, producing antigens involved in halothane-induced hepatitis Phol et al, 1991;Kenna et al, 1993;Chrsiten et al, 1994) and also, 2,2-dichlorotrifluoroethane-related liver disease (Hoet et al, 1997;White et al 2001). Similarly, covalent binding of TCE in vivo has been observed in rodents Bolt and Filser, 1977;Stot et al, 1982;Mazzullo et al, 1992;Stevens et al, 1992;Kautiainen et al, 1997). TCE-oxide and DCAC can covalently modify proteins directly to form protein adducts (Bloemen et al, 2001;Halmes et al, 1996Halmes et al, , 1997.…”
Section: Discussionmentioning
confidence: 97%